BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Melanoma Institute Australia - ECPv6.16.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://melanoma.org.au
X-WR-CALDESC:Events for Melanoma Institute Australia
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Australia/Sydney
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Tokyo
BEGIN:STANDARD
TZOFFSETFROM:+0900
TZOFFSETTO:+0900
TZNAME:JST
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Madrid
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Phoenix
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Australia/Melbourne
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Australia/Melbourne
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260916T170000
DTEND;TZID=Australia/Sydney:20260916T170000
DTSTAMP:20260610T094133
CREATED:20260602T045957Z
LAST-MODIFIED:20260602T045957Z
UID:10000300-1789578000-1789578000@melanoma.org.au
SUMMARY:MRFF International Clinical Trial Collaborations
DESCRIPTION:The objective of the Medical Research Future Fund (MRFF) – 2026 International Clinical Trial Collaborations Grant Opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that: \n\nPromote Australian involvement in international collaborative investigator-initiated clinical trials research through the establishment and co-ordination of clinical trial site/s in Australia.\nProvide high-quality evidence of the effectiveness of novel health treatments\, drugs or devices in ‘usual care’ settings\, which will support a decision on whether to deliver the intervention in an Australian setting.\n\nThe anticipated outcome of the research funded by this grant opportunity is to improve the health and wellbeing of Australians by investing in new clinical trials that support increased access to high-quality\, evidence-based and effective health care. \nPlease note the 2026 MRFF International Clinical Trial Collaborations grant opportunity will be open for one round only. \n\nKey Dates:\nMinimum data due: 19 August 2026\nApplications close: 16 September 2026 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/mrff-int-clinical-trial-collaborations/
LOCATION:QLD
CATEGORIES:Grants,Clinical Trial Cohorts
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/MRFF-International-Clinical-Trial-Collaborations-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261008
DTEND;VALUE=DATE:20261014
DTSTAMP:20260610T094133
CREATED:20260331T012601Z
LAST-MODIFIED:20260331T012601Z
UID:10000277-1791417600-1791935999@melanoma.org.au
SUMMARY:IAP Congress
DESCRIPTION:It is with great pleasure that we welcome you to the 2026 XXXVI Congress of the International Academy of Pathology in Fukuoka\, bringing together the most enthusiastic and dedicated scholars in the field of pathology. Our goal is to create a unique platform where the latest advancements\, challenges\, and debates in diagnostic and molecular pathology are shared and discussed. \nThis biennial international congress on pathology will be held jointly with the 72nd Autumn Annual Meeting of the Japanese Society of Pathology\, which is held annually in Japan. \nAs the theme of this year’s congress is “Vision for the Future”\, we would like to hold a joint session in the sense of a new challenge that is not bound by the conventional format for the continued development of IAP. Key topics in molecular pathology including spatial transcriptome analysis and artificial intelligence will be explored across various subspecialties\, reflecting the evolving landscape of our field. We will also provide the programs on basic issues in pathology such as the educational system and infectious diseases. \nLocation: Fukuoka International Congress Center\, Fukuoka Sunpalace\, Fukuoka\, Japan \nKey Dates: \nAbstract Submission Deadline: Friday 10 April 2026\, 17:00 (JST)\nYoung Pathologist Award Application & Abstract Submission: Friday 10 April 2026\, 17:00 (JST)\nIAP Bursary Abstract Submission: Friday 10 April 2026\, 17:00 (JST)\nIAP Bursary Application Deadline: Thursday 30 April 2026\nNotification of Acceptance: June 2026 \nFIND OUT MORE
URL:https://melanoma.org.au/event/iap-congress/
LOCATION:Fukuoka International Congress Center\, 2-1 Sekijōmachi\, Fukuoka\, 8120032\, Japan
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/IAP-2026-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20261014T170000
DTEND;TZID=America/Halifax:20261014T170000
DTSTAMP:20260610T094133
CREATED:20260602T051105Z
LAST-MODIFIED:20260602T051105Z
UID:10000302-1791997200-1791997200@melanoma.org.au
SUMMARY:CDMRP Melanoma Research Program
DESCRIPTION:The Melanoma Research Program (MRP) released program announcements for the following funding opportunities: \n\n\n\n·        Focused Program Award – Rare Melanomas  \nThis award supports a multidisciplinary research program of at least two\, but not more than three\, distinct but complementary research projects addressing an overarching question relevant to rare melanomas. \n·        Idea Award \nThe Idea Award supports innovative\, exploratory\, high-risk/potentially high-reward research. Novelty and innovation are expected to be key aspects of the proposed project. By the end of the Idea Award funding period\, the anticipated outcomes of successful efforts should establish proof of principle and obtain preliminary data to secure follow-on funding. \n·        Melanoma Academy Scholar Award \nSupports the addition of independent\, early career investigators (Scholars) who are no more than seven years from their initial faculty appointment to the Melanoma Research Program (MRP) Melanoma Academy. The Melanoma Academy is a unique\, interactive virtual academy focused on bringing together established investigators and Scholars to develop a network of successful\, highly productive melanoma researchers in a collaborative research and career development environment. \n·        Survivorship Research Award \nThe award addresses the relatively new and underfunded area of melanoma-specific survivorship by supporting a broad range of innovative and impactful research that has the intended outcome of improving the health and well-being of melanoma survivors\, their families and/or their care partners in the near term. Proposed studies focusing exclusively on animal models or considering survival only without consideration of quality of life\, overall health and/or function are not responsive to this funding opportunity. \n·        Team Science Award \nSupports a broad range of hypothesis-driven\, multidisciplinary studies that have a short-term goal of advancing the state of the science in melanoma research and/or patient care. Team science is a synergistic effort that harnesses techniques\, approaches and perspectives from multiple disciplines and/or therapeutic areas to address complex\, multi-dimensional problems that will impact patient outcomes. \nKey Dates: \nSubmission Deadline (Pre-application-Pre-Proposal): 13 July 2026\nFocused Program Award – Rare Melanomas\nIdea Award\nTeam Science Award \nSubmission Deadline (Pre-application-Pre-Proposal): 22 September 2026\nMelanoma Academy Scholar Award\nSurvivorship Research Award \nApplication Submission Deadline: 14 October 2026 \n\n\n\n\n\n\n\n\n\nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/cdmrp-melanoma-program/
LOCATION:QLD
CATEGORIES:Grants,Discovery
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/CDMRP-Research-Program-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261023
DTEND;VALUE=DATE:20261028
DTSTAMP:20260610T094133
CREATED:20260302T035935Z
LAST-MODIFIED:20260302T035935Z
UID:10000257-1792713600-1793145599@melanoma.org.au
SUMMARY:ESMO Congress
DESCRIPTION:The ESMO Congress is a highly influential global oncology meeting for clinicians\, researchers\, patient advocates\, journalists and healthcare industry representatives from all over the world. \nESMO 2026 will be a platform for breakthroughs in oncology research\, clinical practice and patient care. Participants can expect impactful new data\, interactive education\, excellent networking opportunities and an innovative exhibition area. By attending the ESMO Congress 2026\, oncologists will not only gain insights into the latest developments but also play an active role in shaping the future of oncology on a global scale. \nA comprehensive educational and scientific programme will foster the exchange and debate of translational cancer science\, highlight the first announcements of potentially practice-changing data\, and stimulate multidisciplinary discussions aimed at improving treatment options for patients. \nLearning objectives: \n\nTo stay informed about current approaches in cancer prevention\, screening\, and early detection\nTo gain insights into the latest advances in basic\, translational\, and clinical cancer research\nTo explore the clinical implications of scientific breakthroughs in cancer biology\, diagnostics\, and treatment\nTo be updated on state-of-the-art therapeutic strategies for patients with cancer\nTo examine the emerging role of artificial intelligence in cancer diagnosis\, research and therapy\n\nLocation: IFEMA Madrid\, Madrid\, Spain \nKey Dates: \nEarly Registration Deadline: 22 July 2026 at 23:59 CEST\nAbstract Submission Deadline: 12 May 2026 at 21:00 CEST\nLate-Breaking Abstract Submission Deadline: 8 September 2026 at 21:00 CEST\nConference Dates: 23 October 2026 – 27 October 2026 \nFIND OUT MORE
URL:https://melanoma.org.au/event/esmo-congress/
LOCATION:IFEMA Madrid\, Avda. Del Partenon\, 5\, Madrid\, 28042\, Spain
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/02/ESMO_2026-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261104
DTEND;VALUE=DATE:20261107
DTSTAMP:20260610T094133
CREATED:20260505T061045Z
LAST-MODIFIED:20260505T061045Z
UID:10000283-1793750400-1794009599@melanoma.org.au
SUMMARY:ESSO Congress
DESCRIPTION:The Annual Congress of the European Society of Surgical Oncology (ESSO) is the leading event in Europe dedicated to advancing surgical cancer care. \nBringing together oncology surgeons\, researchers\, and healthcare professionals from across the globe\, the ESSO Congress offers a dynamic platform for sharing cutting-edge research\, surgical innovations\, and multidisciplinary approaches to cancer treatment. \nWith a strong focus on education\, collaboration\, and excellence in patient outcomes\, the congress fosters dialogue\, drives progress\, and shapes the future of surgical oncology. \nWith the theme Surgical Oncology without Borders: Innovations and Challenges Worldwide\, we will explore the latest advancements\, global perspectives\, and shared challenges that shape the future of Surgical Oncology around the world. \nLocation: IFEMA Madrid\, Spain \nKey Dates: \nAbstract submission deadline: 6 May 2026\nAbstract review results: 6 July 2026\nEarly registration deadline: 19 August 2026 \nFIND OUT MORE
URL:https://melanoma.org.au/event/esso_congress/
LOCATION:IFEMA Madrid\, Avda. Del Partenon\, 5\, Madrid\, 28042\, Spain
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/04/ESSO_2026_1-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261104
DTEND;VALUE=DATE:20261109
DTSTAMP:20260610T094133
CREATED:20260505T061518Z
LAST-MODIFIED:20260506T001943Z
UID:10000284-1793750400-1794182399@melanoma.org.au
SUMMARY:SITC Annual Meeting
DESCRIPTION:SITC 2026 is the premier international conference focused on cancer immunotherapy\, bringing together leaders from academia\, regulatory agencies\, government\, and industry for education\, scientific exchange\, and networking. \nThe conference provides a multidisciplinary educational and interactive environment focused on improving outcomes for cancer patients by incorporating strategies based on basic and applied cancer immunotherapy. \nWhy attend SITC 2026? \n\nCutting-edge sessions by IO experts (Don’t miss over 40 sessions on the latest IO research)\nIn-person networking opportunities with IO luminaries\nAccess the latest immuno-oncology research\n\nLocation: Phoenix Convention Center\, Phoenix\, Arizona\, United States \nKey Dates: \nRegular and early career investigator award abstract submission deadline: 25 June 2026\nAbstract notifications: 31 July 2026\nLate-breaking abstract submission deadline: 10 September 2026\nAbstract notifications: 28 September 2026 \nFIND OUT MORE
URL:https://melanoma.org.au/event/sitc_meeting/
LOCATION:Phoenix Convention Center\, 100 N 3rd Street\, Phoenix\, AZ\, United States
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/04/SITC_2026-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261109
DTEND;VALUE=DATE:20261113
DTSTAMP:20260610T094133
CREATED:20260602T051747Z
LAST-MODIFIED:20260602T051747Z
UID:10000294-1794182400-1794527999@melanoma.org.au
SUMMARY:IPOS Annual World Congress
DESCRIPTION:The annual IPOS World Congress of Psycho-Oncology and Psychosocial Academy brings together professionals in diverse fields from around the globe who dialogue about improving cancer care on an international level and developing strategies to add psychosocial issues to all aspects of cancer control. The attendees include\, but are not limited to\, psychologists\, psychiatrists\, physicians\, nurses\, social workers\, social scientists\, patient advocates\, educators and administrators\, dieticians\, epidemiologists\, spiritual care specialists\, and vocational rehabilitation specialists. \nThe congress offers three days of symposia\, podium presentations and posters addressing a variety of disciplines within cancer supportive care. The congress is held in conjunction with the Psychosocial Academy which offers one day of training workshops and presentations. \nThe theme of the congress is «Towards a sustainable psycho-oncology: of all and for all». In the twenty-first century\, there is no longer any doubt about the need to address the psychological aspects of cancer patients and their families\, nor about the necessity of incorporating it in patient care throughout the entire cancer journey. It is time to make psycho-oncology a reality across the entire healthcare and social support network for people living with cancer all over the world. \n\n\n\n\n\n\nLocation: Hotel Barceló Sants\, Barcelona\, Spain \n\n\n\n\n\nKey Dates: \nAbstract Submission Deadline: 15 July 2026\nAbstract Decision Notification: August 2026\nPresenting Author Registration and Payment Deadline: 1 October 2026\nWorkshop Submission Deadline: 1 July 2026\nEarly Bird Registration Deadline: 11 August 2026 \nFIND OUT MORE
URL:https://melanoma.org.au/event/ipos-congress/
LOCATION:Hotel Barceló Sants\, Pl. dels Països Catalans\, s/n\, Sants-Montjuïc\, Barcelona\, 08014\, Spain
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/IPOS-Congress600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261111
DTEND;VALUE=DATE:20261114
DTSTAMP:20260610T094133
CREATED:20260331T011646Z
LAST-MODIFIED:20260331T011646Z
UID:10000281-1794355200-1794614399@melanoma.org.au
SUMMARY:COSA Annual Scientific Meeting
DESCRIPTION:We are honoured to co-convene the 2026 COSA Annual Scientific Meeting (ASM) to be held at the International Convention Centre (ICC) Sydney from Wednesday 11 to Friday 13 November 2026\, with pre-conference workshops being held on Tuesday 10 November. \nThe theme for the 2026 COSA ASM is The precision generation: From cancer prevention to personalised care. \n\n\n\n\n\n\n\n\n\n\nThis theme reflects how far cancer care has evolved; from a one-size-fits-all rigid approach\, to care that is increasingly tailored to the individual\, across the entire cancer journey. \nThe disease theme will have a strong focus on lung cancers\, alongside sessions addressing head and neck cancers\, early-onset cancers such as colorectal cancer\, and brain cancer\, including both primary and metastatic disease. As always\, equity will be embedded throughout the program\, reflecting COSA’s ongoing commitment to improving outcomes for all people affected by cancer. \nIt has been almost a decade since the COSA ASM was held in Sydney\, so we are excited to bring it back to showcase the remarkable advances that have transformed cancer care over this time\, including the molecular biomarker realm and the evolution of novel transformative therapeutics. \nAustralia has developed deep expertise across clinical care\, research and clinical trials\, implementation and policy\, and the program will highlight this local leadership alongside contributions from international experts in the fields of drug development\, precision oncology\, pharmacogenomics and palliative and supportive care. \n\n\n\n\n\nLocation: International Convention Centre (ICC)\, Sydney\, Australia \nKey Dates: \nDelegate Designed Symposia Submissions Close: 3 July 2026\nAbstract Submissions Close: 7 August 2026\nAbstract Decision Notification: 2 September 2026\nAbstract Acceptance by Presenter: 11 September 2026\nEarly Bird Registration Deadline: 11 September 2026\nPre-conference Workshops: 10 November 2026 \nFIND OUT MORE
URL:https://melanoma.org.au/event/cosa-scientific-meeting/
LOCATION:ICC Sydney and Cockle Bay – Darling Harbour\, 14 Darling Dr\, Sydney\, NSW\, 2000\, Australia
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/Cosa-Asm-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20261111T170000
DTEND;TZID=Australia/Sydney:20261111T170000
DTSTAMP:20260610T094133
CREATED:20260331T013110Z
LAST-MODIFIED:20260331T013110Z
UID:10000276-1794416400-1794416400@melanoma.org.au
SUMMARY:NHMRC Partnership Projects
DESCRIPTION:The Partnership Project funding scheme provides funding and support to create new opportunities for researchers and policy makers to work together to define research questions\, undertake research\, interpret the findings and implement the findings into policy and practice. \n\nPartnership Projects create partnerships among decision makers\, policy makers\, managers\, clinicians and researchers and answer a specific research question to influence health and wellbeing through changes in the delivery\, organisation\, funding and access to health services. \nPartnership Projects will support collaborations\, within the Australian context\, that translate research evidence into health policy and health practice\, to improve health services and processes. \nThe objectives of the Partnership Project scheme are to: \n• Meet the need for more effective integration of research evidence into health policy and service delivery\n• Create partnerships among policy makers\, managers\, service providers and researchers\n• Provide support to answer often complex and difficult questions that policy makers\, managers and service providers face when making decisions and implementing policies that affect Australians’ health and health care\n• Be highly responsive to the priorities of government\, the community and health professionals\n• Enable applicants to apply for funding at any time during the year to allow researchers and Partner Organisations to develop timely collaborations. \n\nKey Dates for Peer Review Cycle 2:\nApplications open: 19 March 2026\nNHMRC-approved Administering Institutions waiver due: 8 July 2026\nMinimum data due: 22 July 2026\nApplications close: 5 August 2026\nPeer review meetings: 17-19 November 2026 \nKey Dates for Peer Review Cycle 3:\nApplications open: 23 July 2026\nNHMRC-approved Administering Institutions waiver due: 14 October 2026\nMinimum data due: 28 October 2026\nApplications close: 11 November 2026\nPeer review meetings: 2-4 March 2027 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/nhmrc-partnership-projects/
LOCATION:QLD
CATEGORIES:Grants,Industry
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/NHMRC-Partnership-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261119
DTEND;VALUE=DATE:20261122
DTSTAMP:20260610T094133
CREATED:20260302T042655Z
LAST-MODIFIED:20260302T042655Z
UID:10000258-1795046400-1795305599@melanoma.org.au
SUMMARY:Australasian Melanoma Conference
DESCRIPTION:The Australasian Melanoma Conference 2026 is a premier event for professionals involved in melanoma and skin cancer research\, diagnosis\, and clinical management. The conference will present new discoveries from basic science and explore cutting-edge paradigms in melanoma and skin cancer care. It is designed for clinicians\, researchers\, and healthcare professionals seeking the latest updates in the field and opportunities for networking and collaboration. \nThe AMC 2026 conference program will feature a broad range of speakers across multi disciplines and concurrent sessions under the key categories of: \n\nPrevention\nEarly Detection\nAdvanced Diseases\nSurvivorship\n\nLocation: Sofitel Melbourne on Collins\, Melbourne\, Australia \nKey Dates: \nConference Dates: 19 November 2026 – 21 November 2026\nEarly Bird Registration Deadline: 31 July 2026\nAbstract Submission Deadline: 17 April 2026 at 11:59 PM (AEST) \nFIND OUT MORE
URL:https://melanoma.org.au/event/amc-2026/
LOCATION:Sofitel Melbourne on Collins\, 25 Collins Street\, Melbourne\, Victoria\, 3000\, Australia
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/02/AMC-2026-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261130
DTEND;VALUE=DATE:20261204
DTSTAMP:20260610T094133
CREATED:20260602T054510Z
LAST-MODIFIED:20260602T054510Z
UID:10000296-1795996800-1796342399@melanoma.org.au
SUMMARY:Melanoma and Immunotherapy Bridge
DESCRIPTION:Upcoming annual appointments for worldwide cancer clinicians and researchers\, gaining more and more attendees every year\, the 11th edition of Immunotherapy Bridge and the 16th edition of Melanoma Bridge will be held in Naples (Italy) from November 30th to December 1st and from December 1st to 3rd\, respectively. \nThe first session of Immunotherapy Bridge will be jointly organized with the Society for ImmunoTherapy of Cancer and dedicated to the Modulator of Tumor Immunity and Immunotherapy. An in depth analysis of the drivers of organ specific immune response\, the novel drugs development\, the actual landscape and future perspectives on the field of cancer vaccines and the neoadjuvant therapies across cancers will follow. \nThe scientific program of Melanoma Bridge will be dedicated to the most pressing of the unanswered questions\, the translational research in melanoma and the most valuable emerging strategies. \nBoth Immunotherapy and Melanoma Bridge meetings will host a “Great Debate” session\, where counterpoint views from leading experts on specific controversial clinical issues will be presented\, discussed and evaluated by the audience. \n\n\n\n\n\n\nLocation: Royal Continental Hotel Naples\, Italy \n\n\n\n\n\nKey Dates \nAbstract Submission Deadline: 5 October 2026\nAbstract Decision Notification: 30 October 2026 \nFIND OUT MORE
URL:https://melanoma.org.au/event/melanoma-immunotherapy-bridge/
LOCATION:Royal Continental Hotel Naples\, Via Partenope 38/44\, Naples\, 80121\, Italy
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/Melanoma_Bridge600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261130
DTEND;VALUE=DATE:20261205
DTSTAMP:20260610T094133
CREATED:20260602T053522Z
LAST-MODIFIED:20260602T053522Z
UID:10000295-1795996800-1796428799@melanoma.org.au
SUMMARY:ASI Annual Scientific Meeting
DESCRIPTION:The ASI 2026 Local Organising Committee warmly invites you to join us for the 54th Annual Scientific Meeting of the Australian and New Zealand Society for Immunology (ASI)\, to be held 30 November – 4 December 2026 in Canberra (Ngunnawal Country)\, Australia’s national capital. \nSet in one of the world’s most sustainable and liveable cities\, Canberra offers the perfect setting for a week of discovery\, connection\, and scientific excellence. Our comprehensive program will spotlight the leading immunological research from Australia\, New Zealand and around the world. The program will include a wide range of topics covering cutting-edge fundamental\, translational\, and clinical immunology—from infection\, inflammation\, and autoimmunity to tumour immunology\, and immunometabolism. \nOur meeting venue\, QT Canberra\, provides an intimate environment designed to support vibrant discussion and collaboration. Set close to the city centre\, on the shores of Lake Burley Griffin\, you will be within easy reach to a thriving food and wine scene\, national museums and galleries and scenic outdoor spaces providing every opportunity to immerse yourself in the best Canberra has to offer. \nWe look forward to welcoming you to ASI 2026 in Canberra—a meeting that promises rich scientific exchange\, renewed connections\, and an engaging celebration of our immunology community. \n\n\n\n\n\nLocation: QT Canberra\, Canberra\, Australia \nKey Dates: \nAbstract Submission Deadline: mid-late August 2026\nAbstract Decision Notification: Sep – Oct 2026\nEarly Bird Registration Deadline: mid-late August 2026\nStandard Registration Deadline: 23 November 2026 \n\n\n\n\n\nFIND OUT MORE
URL:https://melanoma.org.au/event/asi-annual-meeting/
LOCATION:QT Canberra\, 1 London Cct\, Canberra\, 2601\, Australia
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/ASI_2026-600-x-338-px.jpg
END:VEVENT
END:VCALENDAR